10.6084/m9.figshare.5797572.v1
Tian-li Xia
Tian-li
Xia
Fang-yang Huang
Fang-yang
Huang
Yi-ming Li
Yi-ming
Li
Hua Chai
Hua
Chai
Bao-tao Huang
Bao-tao
Huang
Yuan-Wei-Xiang Ou
Yuan-Wei-Xiang
Ou
Qiao Li
Qiao
Li
Xiao-bo Pu
Xiao-bo
Pu
Zhi-liang Zuo
Zhi-liang
Zuo
Yong Peng
Yong
Peng
Mao Chen
Mao
Chen
De-jia Huang
De-jia
Huang
Additional file 4: of The impact of age on the implementation of evidence-based medications in patients with coronary artery disease and its prognostic significance: a retrospective cohort study
Springer Nature
2018
Coronary artery disease
Elderly
Evidence-based medications
Mortality
2018-01-17 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_The_impact_of_age_on_the_implementation_of_evidence-based_medications_in_patients_with_coronary_artery_disease_and_its_prognostic_significance_a_retrospective_cohort_study/5797572
Multivariate Coxâs proportional hazards regression model on combination therapy of EBMs. Adjusted factor: sex, history of hypertension, history of diabetes mellitus, and history of heart failure, history of dyslipidemia, smoking status, eGFR and hepatic enzymes. Model 0: no medication; model 1: prescribed 1 type of EBMs; model 2, prescribed 2 types of EBMs; model 3, prescribed all 3 types of EBMs. Three types of EBMs included: statin, beta-blockers, and RAAS inhibitors (ACEIs or ARBs). Abbreviations: EBMs: evidence-based medications, CAD: coronary artery disease, CI: confidence interval, CV death: cardiovascular death, HR: hazard ratio. (DOCX 13 kb)